Stem Cell Therapy In Utero

October 15, 2015

(The Scientist) – Researchers in Sweden and the U.K. have announced that they will begin a stem cell clinical trial in several months to treat brittle bone disease, a rare disorder that causes frequent bone fractures, impaired growth, and even death. The plan is to deliver stem cells that will produce collagen and strengthen bones—half of the babies will receive the therapy in utero, the other half shortly after birth.